专利检索 ap:("Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts") AND inv:"Whitley, Corinna" 第 1 页

1.

发明公开
HCBI, MSBI, MSSI AND CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES 审中-公开

公开(公告)号：EP4089183A1

公开(公告)日：2022-11-16

申请号：EP22167943.4

申请日：2015-07-09

申请人： Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts

发明人： de Villiers-zur Hausen, Ethel-Michele , zur Hausen, Harald , Gunst, Karin , Whitley, Corinna , Lamberto, Pérez Iranzu

IPC分类号： C12Q1/6883 , C12Q1/70 , C12Q1/6886

摘要： Described are HCBI (Healthy Cattle Blood Isolate), MSBI (Multiple Sclerosis Brain Isolate), MSSI (Multiple Sclerosis Serum Isolate) and CMI (Cow Milk Isolate) nucleotide sequences as well as probes and primers comprising part of said nucleotide sequences and antibodies against polypeptides encoded by said nucleotide sequences. Said compounds are useful as early markers for the future development of cancer and diseases of the CNS (Multiple sclerosis MS, Prion-linked diseases, amyotrophic lateral sclerosis, transmissible spongiforme encephalitis, Parkinson's disease, Alzheimer disease) and should represent targets for treatment and prevention.